Grey Wolf Therapeutics Limited
10989365
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 27/10/2025
Due 10/11/2026
Industry
Officers
director · Since 29/09/2017
COMPANY DIRECTOR
AUSTRALIAN · UNITED KINGDOM · Age 59
Also on 2 other boards
director · Since 29/03/2018
BLANK
AMERICAN · UNITED STATES · Age 63
Also on 1 other board
director · Since 23/12/2022
PRINCIPAL PFIZER VENTURES (BIOTECH INVES
AMERICAN · UNITED STATES · Age 56
Also on 1 other board
director · Since 25/11/2024
SENIOR PARTNER, OXFORD SCIENCE ENTERPRIS
FRENCH · UNITED KINGDOM · Age 59
Also on 1 other board
secretary · Since 01/05/2025
director · Since 02/03/2026
BRITISH · UNITED KINGDOM · Age 59
Also on 4 other boards
Persons with Significant Control
Former PSCs
Thomas David Mccarthy
Ceased 29/03/2018
Mr Peter Joyce
Ceased 29/03/2018
Biodiscovery 5 Fpci
Ceased 12/02/2019
Canaan Xi L.P.
Ceased 12/02/2019
CompanyRankvs 138+ SIC 72110 peers83
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£26.3M
Balance sheet strength
Cash
£20.4M
Cash in the bank
Net Current Assets
£26.2M
Working capital
Current Assets
£28.8M
Current Liabilities
£2.6M
Fixed Assets
£63k
Debtors
£8.4M
Profit After Tax
-£16.1M
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 11.04 | +£12.9M |
| 2023 | 6.71 | +£3.2M |
| 2022 | 11.83 | +£806k |
| 2020 | 13.85 | — |
Derived from filed accounts. Not audited figures.